PyroGenesis Inc.
PYRGF
$0.37
-$0.0152-3.95%
| Weiss Ratings | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.89 | |||
| Price History | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -12.32% | |||
| 30-Day Total Return | -10.86% | |||
| 60-Day Total Return | -16.48% | |||
| 90-Day Total Return | -36.21% | |||
| Year to Date Total Return | -11.93% | |||
| 1-Year Total Return | 3.35% | |||
| 2-Year Total Return | -62.63% | |||
| 3-Year Total Return | -78.49% | |||
| 5-Year Total Return | 31.16% | |||
| 52-Week High % Change | -51.73% | |||
| 52-Week Low % Change | 32.83% | |||
| Price | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.80 | |||
| 52-Week Low Price | $0.29 | |||
| 52-Week Low Price (Date) | Apr 10, 2024 | |||
| 52-Week High Price (Date) | Jul 15, 2024 | |||
| Valuation | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 71.67M | |||
| Enterprise Value | 78.24M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.07 | |||
| Earnings Per Share Growth | -45.25% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 6.62 | |||
| Price/Book (Q) | -18.52 | |||
| Enterprise Value/Revenue (TTM) | 7.36 | |||
| Price | $0.37 | |||
| Enterprise Value/EBITDA (TTM) | -8.41 | |||
| Enterprise Value/EBIT | -7.92 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 182.27M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 514 937 0002 | |||
| Address | 1744 William Street Montreal, QC H3J 1R4 | |||
| Website | www.pyrogenesis.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -92.91% | |||
| Profit Margin | -115.16% | |||
| Management Effectiveness | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -26.82% | |||
| Return on Equity | -- | |||
| Income Statement | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 10.63M | |||
| Total Revenue (TTM) | 10.63M | |||
| Revenue Per Share | $0.06 | |||
| Gross Profit (TTM) | 3.13M | |||
| EBITDA (TTM) | -9.30M | |||
| EBIT (TTM) | -9.87M | |||
| Net Income (TTM) | -12.24M | |||
| Net Income Avl. to Common (TTM) | -12.24M | |||
| Total Revenue Growth (Q YOY) | 6.80% | |||
| Earnings Growth (Q YOY) | 39.35% | |||
| EPS Diluted (TTM) | -0.07 | |||
| EPS Diluted Growth (Q YOY) | 40.38% | |||
| Balance Sheet | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 28.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 11.57M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -3.81M | |||
| Current Ratio (Q) | 0.601 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 18.78M | |||
| Total Current Liabilities (Q) | 19.25M | |||
| Total Debt (Q) | 7.02M | |||
| Total Liabilities (Q) | 22.59M | |||
| Total Common Equity (Q) | -3.81M | |||
| Cash Flow | PYRGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 2.63M | |||
| Cash from Financing (TTM) | 1.81M | |||
| Net Change in Cash (TTM) | -632.10K | |||
| Levered Free Cash Flow (TTM) | -2.95M | |||
| Cash from Operations (TTM) | -5.07M | |||
